Suppr超能文献

从脂蛋白去除血清中分离和鉴定人载脂蛋白A-IV。

Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum.

作者信息

Weinberg R B, Scanu A M

出版信息

J Lipid Res. 1983 Jan;24(1):52-9.

PMID:6833882
Abstract

Human apolipoprotein A-IV is an acidic polypeptide of molecular weight 46,000 that is secreted into lymph on the surface of nascent chylomicrons, but which exists in circulation unassociated with lipoproteins. Previous studies of this protein have utilized material isolated from a d < 1.006 g/ml fraction of human serum and from human lymph. Although it has been suggested that apoA-IV circulating in plasma is the product of dissociation from the surface of nascent chylomicrons, it has been characterized by immunological techniques only. We have isolated human apoA-IV on a preparative scale from lipoprotein-depleted serum using a technique of adsorption to a phospholipid-triglyceride emulsion, followed by delipidation and preparative gel electrophoresis. The molecular weight, pI, and amino acid composition of material thus prepared agree with literature values for apoA-IV derived from chylomicrons. We have determined that apoA-IV is a glycoprotein containing 6% carbohydrate by weight (mannose 1.8%, galactose 1.55%, N-acetyl glucosamine 1.55%, sialic acid 1.1%). Electroimmunoassay of human serum using a monospecific rabbit antibody to serum-derived apoA-IV found 13.1 +/- 1.8 mg/dl, a value in agreement with determinations using antibodies to chylomicron-derived apoA-IV. We conclude that apoA-IV may be easily purified from normal human serum, and that the material thus isolated has identical chemical, physical, and immunological properties to apoA-IV obtained from human lymph. It is therefore likely that the dissociation of apoA-IV from the surface of nascent chylomicrons following their entry into circulation is not attended by changes in the structure or composition of this apoprotein.-Weinberg, R. B., and A. M. Scanu. Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum.

摘要

人载脂蛋白A-IV是一种分子量为46,000的酸性多肽,它分泌到新生乳糜微粒表面的淋巴中,但在血液循环中以与脂蛋白不相关的形式存在。此前对该蛋白的研究使用了从人血清密度小于1.006 g/ml的组分以及人淋巴中分离得到的物质。尽管有人提出血浆中循环的载脂蛋白A-IV是从新生乳糜微粒表面解离的产物,但仅通过免疫技术对其进行了表征。我们使用吸附到磷脂 - 甘油三酯乳液上的技术,随后进行脱脂和制备性凝胶电泳,从无脂蛋白血清中大规模分离出人载脂蛋白A-IV。由此制备的物质的分子量、pI和氨基酸组成与源自乳糜微粒的载脂蛋白A-IV的文献值一致。我们确定载脂蛋白A-IV是一种糖蛋白,按重量计含有6%的碳水化合物(甘露糖1.8%、半乳糖1.55%、N-乙酰葡糖胺1.55%、唾液酸1.1%)。使用针对血清来源的载脂蛋白A-IV的单特异性兔抗体对人血清进行电免疫测定,结果为13.1±1.8 mg/dl,该值与使用针对乳糜微粒来源的载脂蛋白A-IV的抗体的测定结果一致。我们得出结论,载脂蛋白A-IV可以很容易地从正常人血清中纯化出来,并且由此分离得到的物质在化学、物理和免疫学性质上与从人淋巴中获得的载脂蛋白A-IV相同。因此,新生乳糜微粒进入循环后,载脂蛋白A-IV从其表面解离时,该载脂蛋白的结构或组成可能不会发生变化。 - 温伯格,R. B.,和A. M. 斯卡努。从无脂蛋白血清中分离和表征人载脂蛋白A-IV。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验